Biomea Fusion announced its Q3 2026 financial results and clinical progress, including completed enrollment in a Phase II trial for icovamenib in insulin-deficient type 2 diabetes and ongoing enrollment in another Phase II trial for patients not meeting glycemic targets on GLP-1 therapy. The company also reported positive Phase I results for BMF-650, an oral GLP-1 receptor agonist showing weight reduction and good tolerability. First patient dosing began in a combination trial of icovamenib with semaglutide. Cash runway extends into Q2 2027, with several important Phase II data readouts anticipated throughout 2027, positioning Biomea Fusion for potential strategic partnerships and further development.
Biomea Fusion's Q3 2026 financial results and clinical updates provide context for readers. For those following the Health sector, here is Pluang's market snapshot as of Nov 11, 2026 04:02 WIB: Of 150 priced Health-sector US stocks, 52 rose and 97 fell today. Notable movers include LQDA at USD 51.44 with a 1-day change of +7.46% and a near-even Pluang order activity split of 49% Sell / 51% Buy, TLRY at USD 2.65 down -6.84% with 56% Sell / 44% Buy, and NUWE at USD 5.27 up +6.68% but with 100% Sell orders. The most notable figure is LQDA's 7.46% gain.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
